Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:52 UTC |
---|
Update Date | 2022-03-07 02:52:04 UTC |
---|
HMDB ID | HMDB0015689 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Antazoline |
---|
Description | Antazoline is only found in individuals that have used or taken this drug. It is a 1st generation antihistamine that also anticholinergic properties used to relieve nasal congestion and in eye drops, usually in combination with naphazoline, to relieve the symptoms of allergic conjunctivitis.Antazoline binds to the histamine H1 receptor. This blocks the action of endogenous histamine, which subsequently leads to temporary relief of the negative symptoms brought on by histamine. |
---|
Structure | C(N(CC1=CC=CC=C1)C1=CC=CC=C1)C1=NCCN1 InChI=1S/C17H19N3/c1-3-7-15(8-4-1)13-20(14-17-18-11-12-19-17)16-9-5-2-6-10-16/h1-10H,11-14H2,(H,18,19) |
---|
Synonyms | Value | Source |
---|
2-(N-Benzylanilinomethyl)-2-imidazoline | ChEBI | 2-(N-Phenyl-N-benzylaminomethyl)imidazoline | ChEBI | 4,5-Dihydro-N-phenyl-N-phenylmethyl-1H-imidazole-2-methanamine | ChEBI | Antazolina | ChEBI | Antazolinum | ChEBI | Phenazolin | HMDB | Phenazoline | HMDB | Antistine | HMDB | Arithmin | HMDB | Lannett brand OF antazoline phosphate | HMDB | Imidamine | HMDB | Antasten | HMDB | Antazoline hydrochloride | HMDB | Antazoline phosphate | HMDB | Analergine | HMDB | Antazoline phosphate (1:1) | HMDB | Hydrochloride, antazoline | HMDB | Phosphate, antazoline | HMDB |
|
---|
Chemical Formula | C17H19N3 |
---|
Average Molecular Weight | 265.3529 |
---|
Monoisotopic Molecular Weight | 265.157897623 |
---|
IUPAC Name | N-benzyl-N-(4,5-dihydro-1H-imidazol-2-ylmethyl)aniline |
---|
Traditional Name | antazoline |
---|
CAS Registry Number | 91-75-8 |
---|
SMILES | C(N(CC1=CC=CC=C1)C1=CC=CC=C1)C1=NCCN1 |
---|
InChI Identifier | InChI=1S/C17H19N3/c1-3-7-15(8-4-1)13-20(14-17-18-11-12-19-17)16-9-5-2-6-10-16/h1-10H,11-14H2,(H,18,19) |
---|
InChI Key | REYFJDPCWQRWAA-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phenylbenzamines. These are aromatic compounds consisting of a benzyl group that is N-linked to a benzamine. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Phenylmethylamines |
---|
Direct Parent | Phenylbenzamines |
---|
Alternative Parents | |
---|
Substituents | - Phenylbenzamine
- Benzylamine
- Tertiary aliphatic/aromatic amine
- Aniline or substituted anilines
- Dialkylarylamine
- Aralkylamine
- Imidolactam
- 2-imidazoline
- Tertiary amine
- Organoheterocyclic compound
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Carboximidamide
- Amidine
- Carboxylic acid amidine
- Azacycle
- Hydrocarbon derivative
- Organopnictogen compound
- Organonitrogen compound
- Organic nitrogen compound
- Amine
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Antazoline,1TMS,isomer #1 | C[Si](C)(C)N1CCN=C1CN(CC1=CC=CC=C1)C1=CC=CC=C1 | 2573.0 | Semi standard non polar | 33892256 | Antazoline,1TMS,isomer #1 | C[Si](C)(C)N1CCN=C1CN(CC1=CC=CC=C1)C1=CC=CC=C1 | 2449.3 | Standard non polar | 33892256 | Antazoline,1TMS,isomer #1 | C[Si](C)(C)N1CCN=C1CN(CC1=CC=CC=C1)C1=CC=CC=C1 | 3445.5 | Standard polar | 33892256 | Antazoline,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1CCN=C1CN(CC1=CC=CC=C1)C1=CC=CC=C1 | 2783.8 | Semi standard non polar | 33892256 | Antazoline,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1CCN=C1CN(CC1=CC=CC=C1)C1=CC=CC=C1 | 2658.3 | Standard non polar | 33892256 | Antazoline,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1CCN=C1CN(CC1=CC=CC=C1)C1=CC=CC=C1 | 3529.4 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - Antazoline EI-B (Non-derivatized) | splash10-001i-9000000000-1eb3fa441bd25a0e41a3 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Antazoline EI-B (Non-derivatized) | splash10-001i-9000000000-1eb3fa441bd25a0e41a3 | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Antazoline GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-9520000000-acee1c2b85e17e49b750 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Antazoline GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Antazoline GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Antazoline 10V, Positive-QTOF | splash10-014i-4290000000-4ac08a84ab740fb2f33e | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Antazoline 20V, Positive-QTOF | splash10-0006-9310000000-cdc9ceb7906b163a7989 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Antazoline 40V, Positive-QTOF | splash10-0006-9000000000-aeb9552d124a58684bc2 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Antazoline 10V, Negative-QTOF | splash10-03di-0190000000-2a0590deb8d02d0510f6 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Antazoline 20V, Negative-QTOF | splash10-03k9-2590000000-294ec8879dd0fa5e4b8f | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Antazoline 40V, Negative-QTOF | splash10-0kcu-7900000000-a5218dce1e2e912dd19e | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Antazoline 10V, Positive-QTOF | splash10-014i-0090000000-7e22bb674a6dd638c95f | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Antazoline 20V, Positive-QTOF | splash10-014i-5190000000-02163279b08dfe80ac6e | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Antazoline 40V, Positive-QTOF | splash10-0006-9000000000-5c02019daf74a4f6ece3 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Antazoline 10V, Negative-QTOF | splash10-03di-0090000000-eb9a3591bd2583334616 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Antazoline 20V, Negative-QTOF | splash10-001i-3930000000-07adc0d6c79a6a789cfa | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Antazoline 40V, Negative-QTOF | splash10-0059-8900000000-554f4ffa39078b568dc0 | 2021-10-11 | Wishart Lab | View Spectrum |
|
---|
General References | - Figus M, Fogagnolo P, Lazzeri S, Capizzi F, Romagnoli M, Canovetti A, Iester M, Ferreras A, Rossetti L, Nardi M: Treatment of allergic conjunctivitis: results of a 1-month, single-masked randomized study. Eur J Ophthalmol. 2010 Sep-Oct;20(5):811-8. [PubMed:20383847 ]
|
---|